US Tech Q2 2026 Surge: Arrow Electronics +32% Revenue, Onto Innovation Record $343M, Akamai $2.8B AI Commitments

The Quick Take

• Arrow Electronics (ARW) posts 32% revenue growth and 124% EPS surge in Q2 2026, marking its strongest performance in recent years on broad-based semiconductor distribution recovery
• Onto Innovation (ONTO) hits record Q2 revenue of $343 million, up 35% year-over-year, driven by advanced packaging demand tied to AI chip production from major foundries
• Akamai (AKAM) secures $2.8 billion in multi-year commitments and pivots to AI cloud delivery; PAR Technology raises full-year outlook on 19% revenue growth and accelerating AI-driven restaurant tech

US technology and semiconductor-adjacent companies delivered a standout Q2 2026 earnings round, with distribution, semiconductor equipment, cloud infrastructure, and enterprise software names reporting double-digit growth rates and raising full-year outlooks. The results span 34 companies and collectively suggest AI-driven demand is now broad enough to lift a wide swath of tech enablers, not just the hyperscalers themselves.

Arrow Electronics Inc (ARW) reported its strongest quarterly result in years — revenue up 32% and EPS up 124% — driven by broad-based recovery in semiconductor and electronic component distribution across all regions. The result signals that the inventory correction cycle that weighed on distribution in 2024-2025 has fully cleared. Onto Innovation Inc (ONTO) set a record with Q2 revenue of $343 million, a 35% year-over-year increase, as advanced packaging for AI accelerators at major foundries drove unprecedented demand for its metrology and inspection equipment.

Akamai Technologies (AKAM) secured $2.8 billion in multi-year cloud delivery commitments — an acceleration of its strategic pivot from legacy CDN to AI-powered cloud infrastructure services. The company is targeting enterprise customers who need distributed compute and AI inference closer to end-users. PAR Technology Corp (PAR) beat Q2 expectations with 19% revenue growth, raising its full-year outlook as AI-driven restaurant management software gained adoption across multi-unit restaurant chains. BioMarin Pharmaceutical (BMRN) added a biotech dimension to the technology cluster, reporting 20% revenue growth and raised guidance amid successful integration of recent acquisitions and strong VOXZOGO rare disease drug performance.

Synthesized from 34 sources.